Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the transaction, the senior vice president now directly owns 27,645 shares in the company, valued at approximately $895,974.45. This represents a 33.66 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Trupanion Stock Up 2.3 %
TRUP stock opened at $33.20 on Wednesday. The stock’s fifty day simple moving average is $43.50 and its two-hundred day simple moving average is $47.33. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The stock has a market cap of $1.41 billion, a P/E ratio of -144.35, a P/E/G ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Investors Weigh In On Trupanion
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Piper Sandler reduced their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus dropped their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $46.60.
Get Our Latest Research Report on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Consumer Staples Stocks, Explained
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is the Dow Jones Industrial Average (DJIA)?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Are Dividends? Buy the Best Dividend Stocks
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.